Lo 1 Nsaid
Lo 1 Nsaid
Lo 1 Nsaid
NONSTEROIDAL ANTI-
INFLAMMATORY DRUGS (NSAID)
By: Batara, Fera, Suharso dan Sri
A. UNDERSTANDING
Non-steroidal anti-inflammatory drugs (AINs) are pharmacologically active non-homogeneous agents that
primarily work to inhibit prostaglandin production and are used for the treatment of acute and chronic pain with the
properties of reducing pain, fever with inflammation, and accompanied by other pain inflammatory disorders . These drugs
mainly work by inhibiting cyclo-oxygenase enzymes but not for lipoxygenase enzymes. NSAIDs are the most widely
available prescription especially in cases of inflammatory pain due to their strong effect in treating mild to moderate
inflammatory pain. In the preparation of NSAIDs, the most important is the consideration of therapeutic effects and side
effects associated with the mechanism of action of this drug preparation, especially in children. Where NSAIDs can occur in
the most important body organ such as the gastrointestinal tract, heart and kidneys.
AINS effectively reduces pain with mild to moderate intensity as in dental pain. For more severe pain, non-
dependent analgesics are needed, such as tramadol. NSAIDs have an analgesic effect on pain originating from non-viscous
integitors, such as headaches, myalgia and abralgia. Some NSAIDs are generally anti-inflammatory, analgesic, and
antipyretic. For example, ketoprofen, ibuprofen, naproksen, indometason, diclofenac, and others. Its antipyretic effect is only
seen at larger doses than its analgesic effect, and NSAIDs are relatively more toxic than classical antipyretics, so they are
only used for the treatment of joint inflammatory diseases such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis
and gout. Individual responses to NSAIDs can be highly variable even though they belong to the same chemical derivatives.
So failure with drugs can be tried with similar drugs from the same chemical derivatives.
B. THE PAIN AND ITS MANAGEMENT
Pain is a complex, universal, and individual sensation. It is said to be individual because the individual response
to pain is different. Simply put, pain can be interpreted as an unpleasant sensation both sensorially and emotionally related to
the existence of tissue damage or other factors, so that the individual feel tortured, suffered and finally the daily activities and
psychic disturbed.
Five classifications and types of pain:
1. Acute pain (mild, moderate, severe)
2. Chronic pain
3. Superficial pain
4. Somatic pain (bone, skeletal muscle, and joints)
5. Visceral pain or internal pain
Medications used to treat mild pain to moderate pain using nonnarkotic analgesics. These
drugs are effective for dull pain in headache, dysmenorrhea (menstrual pain), pain in
inflammation, minor abrasion, muscle pain, and mild to moderate athritis.
4 Visceral pain (deep pain) Pain from smooth muscles and organs.
NSAIDs are believed to work inhibiting prostaglandin synthesis and inhibiting cellular
responses during inflammation. Most NSAIDs work on peripheral nerve receptors to reduce
transmission and pain relief.
Much of the workings of NSAIDs are based on the constraints of prostaglandin
synthesis, where both types of cyclo-oxygenase are blocked. The cyclo-oxygenase enzyme is
present in 2 isoforms called COX-1 and COX-2. COX-1 is essential in the maintenance of
various functions under normal conditions in various tissues especially the kidneys,
gastrointestinal tract, and platelets. In the gastric mucosa, activation of COX-1 produces
cytoprotective prostacyclin. Cyclooxygenase-2 is induced by various inflammatory stimuli,
including cytokines, endotoxins, growth factors. Thromboaksan A2, which is synthesized
platelets by COX-1 causes platelet aggregation, vasoconstriction and smooth muscle
proliferation. In contrast prostacyclin (PGI2) synthesized by KOKS-2 in the macrovascular
endothelium counteracts these effects and causes inhibition of platelet aggregation, vasodilation,
and anti-proliferative effects.
Ideal NSAIDs should inhibit COX-2 (inflammation) and do not inhibit COX-1 (for
gastric mucosal protection), but in fact inhibit COX-1 and COX-2. NSAIDs also inhibit lypo-
oxygenase (leukotriene formation). Although it has been intensively pursued since the late 1980s,
until now the ideal drug has not been found. Ideal drugs Today there are only three drugs with
somewhat selective work, meaning they are stronger to inhibit COX-2 than COX-1, ie COX-2
inhibitors of nabumeton and meloxicam. The celecoxib drug (Celebrex, 1999) is claimed to not
inhibit COX-1 altogether at the usual dose, but its clinical effects on the safety of the gastric
mucosa have not been ascertained.
Aspirin is 166 times more potent inhibiting COX-1 than COX-2. COX-2 inhibitors
were developed in the search for COX inhibitors for the treatment of inflammation and less pain
causing gastrointestinal toxicity and bleeding. Non-selective non-selective non-steroidal
inflammation is called traditional AINS (AINSt).
Here's a chart of Prostaglandin Biosynthesis:
D. SIDE EFFECTS OF NSAIDs